taurine has been researched along with Cancer of Gastrointestinal Tract in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Braumann, C | 1 |
Gutt, CN | 1 |
Scheele, J | 1 |
Menenakos, C | 1 |
Willems, W | 1 |
Mueller, JM | 1 |
Jacobi, CA | 1 |
Láng, I | 1 |
Feuer, L | 1 |
Nékám, K | 1 |
Szigeti, A | 1 |
Gergely, P | 1 |
Petrányi, G | 1 |
1 trial available for taurine and Cancer of Gastrointestinal Tract
Article | Year |
---|---|
Taurolidine reduces the tumor stimulating cytokine interleukin-1beta in patients with resectable gastrointestinal cancer: a multicentre prospective randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Inter | 2009 |
1 other study available for taurine and Cancer of Gastrointestinal Tract
Article | Year |
---|---|
Glutaurine enhances the depressed NK cell activity of tumor patients.
Topics: Antineoplastic Agents; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Female; Gastroin | 1983 |